cervomed.com (CRVO) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Uzoq muddatli kreditlarning kapitalga nisbati CervoMed Inc. (CRVO) uchun qarz yuklamasi dinamikasini aks ettiradi, bunda joriy daraja 0.00 ni tashkil etadi. CervoMed Inc. (CRVO) bemorlarning kognitiv qobiliyatlarini tiklovchi Lyui tanachalari demensiyasi terapiyasi sohasidagi innovator sifatida tan olingan. Jamoa aksiyalar opsionlari va byurokratiyaning yo'qligi bilan rag'batlantirilgan elita neyrobiologlardan iborat. Shu bilan birga, moliyaviy barqarorlik klinik sinovlar natijalariga bog'liq bo'lib, bu esa likvidlikning qat'iy nazoratini talab qiladi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_CRVO_-_CervoMed-Inc._-_Long-Term-Debt-to-Equity-Ratio "CRVO - CervoMed Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
CervoMed Inc. (CRVO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati CervoMed Inc.|CRVO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati cervomed.com|CRVO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar CervoMed Inc.|CRVO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari CervoMed|Tezkor likvidlik cervomed.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:CRVO (CervoMed, Inc.)
Ushbu ko'rsatkich tashkilotning kapitaliga nisbatan uzoq muddatli majburiyatlarning ulushini o'lchaydi. Koeffitsient moliyaviy avtonomiya darajasini va balans tuzilmasining tashqi zarbalarga chidamliligini belgilaydi. Uzoq muddatli qarzlarning kapitalga nisbati dinamikasi kredit kengayishini yoki qarzlarni kamaytirish strategiyalarini kuzatish imkonini beradi. CervoMed Inc. (CRVO) uchun bu joriy tijorat daromadlari yo'qligi sababli juda muhimdir. Demensiya dori vositalari uchun klinik sinovlarni moliyalashtirish davridagi yuqori qarz darajalari to'lov qobiliyatining yo'qolishi risklarini oshirishi mumkin.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp. (OMER)|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|NMRA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|CGTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAVA (Cassava Sciences Inc)|Uzoq muddatli qarzning kapitalga nisbati ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com COYA|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics Inc (OVID)|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PepGen - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|KLTO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati revivapharma.com|MTVA (metaviatx.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeurAxis Inc. (NRXS) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|PASG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cyclerion Therapeutics|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGN|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati